Doctor profile · Federal record

Dr. Geetha Jonnala, M.D

Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Snellville, GA

  • NPI 1578690467
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 26 yrs in practice
  • Licensed in 2 states
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1567 Janmar RD., Suite 100
Snellville, GA 30078
(770) 972-1022
fax (770) 407-8485

Credentials & registration

NPPES · NUCC
NPI registered
February 2007 — 19 yrs on file
Profile last updated
November 23, 2007
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
Georgia #059086 · Texas #M5258

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1578690467. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
41,106
Distinct HCPCS
10
Medicare allowed
$1,225,775
HCPCS Description Services Patients Avg allowed
J1602 Injection, golimumab, 1 mg, for intravenous use 15,960 23 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 12,150 19 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 5,730 14 $32
J0897 Injection, denosumab, 1 mg 5,460 54 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 768 308 $125
96413 Administration of chemotherapy into vein, 1 hour or less 397 61 $131
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 139 56 $73
96415 Administration of chemotherapy into vein, each additional hour 128 20 $28
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 98 20 $1
99204 New patient office or other outpatient visit, 45-59 minutes 84 84 $162

In context: peer comparison

Among 1 peers in this city , average services per provider: 2,418. This provider delivers 17× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,049
Transactions
143
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 44 $950.01
Amgen Inc. 26 $430.99
GlaxoSmithKline, LLC. 13 $345.95
Janssen Biotech, Inc. 15 $289.67
Novartis Pharmaceuticals Corporation 13 $208.98
GENZYME CORPORATION 2 $161.62
SOBI, INC 6 $132.78
Mallinckrodt Hospital Products Inc. 5 $109.27
E.R. Squibb & Sons, L.L.C. 4 $106.95
AstraZeneca Pharmaceuticals LP 4 $91.75
UCB, Inc. 3 $65.67
PFIZER INC. 3 $44.38
ANI Pharmaceuticals, Inc. 2 $40.46
Genentech USA, Inc. 2 $33.97
Lilly USA, LLC 1 $18.55

By nature of payment

Food and Beverage
$3,010
Education
$39

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,574
Patients
768
Total drug cost
$948,437
Drug Type Claims Patients Total cost
Prednisone Generic 275 173 $1,499
Duloxetine Hcl Generic 217 95 $4,424
Hydroxychloroquine Sulfate Generic 169 85 $12,037
Methotrexate (Methotrexate Sodium) Brand 166 85 $6,417
Tramadol Hcl Generic 154 55 $739
Pregabalin Generic 139 69 $9,008
Leflunomide Generic 92 49 $5,243
Gabapentin Generic 79 40 $1,299
Alendronate Sodium Generic 55 33 $574
Trazodone Hcl Generic 54 28 $823

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Geetha Jonnala's medical specialty?
Dr. Geetha Jonnala practices Rheumatology Physician in Snellville, GA.
Where does Dr. Geetha Jonnala practice?
Dr. Geetha Jonnala practices at 1567 Janmar RD., Snellville, GA 30078. Office phone: 7709721022.
What is Dr. Geetha Jonnala's NPI?
Dr. Geetha Jonnala's National Provider Identifier (NPI) is 1578690467, issued by NPPES.
Does Dr. Geetha Jonnala accept Medicare assignment?
Yes. Dr. Geetha Jonnala accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Geetha Jonnala commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.